论文部分内容阅读
据2010年5-7月美国《科学》杂志上的两篇独立论文报道,MicroRNA-33有助于调节高密度脂蛋白胆固醇的动态平衡。这意味着它或许能够成为心血管疾病和新陈代谢疾病的潜在标靶。
MicroRNA-33 helps regulate the homeostasis of high-density lipoprotein cholesterol, according to two separate articles in the May-July 2010 issue of the journal Science. This means it may be a potential target for cardiovascular and metabolic diseases.